Kineta (STU:J75) Accounts Payable & Accrued Expense : €7.56 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kineta Accounts Payable & Accrued Expense?

Kineta's quarterly accounts payable & accrued expense increased from Dec. 2023 (€4.09 Mil) to Mar. 2024 (€6.59 Mil) and increased from Mar. 2024 (€6.59 Mil) to Jun. 2024 (€7.56 Mil).

Kineta's annual accounts payable & accrued expense increased from Dec. 2021 (€1.55 Mil) to Dec. 2022 (€8.82 Mil) but then declined from Dec. 2022 (€8.82 Mil) to Dec. 2023 (€4.09 Mil).

Kineta Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kineta's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Accounts Payable & Accrued Expense Chart

Kineta Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

1.11

1.55

8.82

4.09

Kineta Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							6.57	4.55	4.09	6.59	7.56

Kineta Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kineta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

KANT:USA

Address

7683 SE 27th Street, Suite 481, Mercer Island, WA, USA, 98040

Website

https://www.kinetabio.com

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.

Kineta Headlines

No Headlines